BAKER BROS ADVISORS LLC Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | X | 0.68 | 56,853 | 38,376 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | X | 0.68 | 2,296,890 | 1,550,401 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | X | 0.68 | 238,850 | 161,224 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 26,292,961 | 0 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,912,167 | 0 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 582,747 | 0 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 44,572,171 | 0 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 4,382,118 | 0 | 0 | |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 24.00 | 1,723,306 | 41,359,344 | 1,723,306 | 0 to 1.7 M |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 24.00 | 189,374 | 4,544,976 | 189,374 | 0 to 189.4 K |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | X | 0.68 | 56,853 | 38,376 | 639,600 | 582.7 K to 639.6 K (+9.76 %) |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | X | 0.68 | 2,296,890 | 1,550,401 | 73,162,022 | 70.9 M to 73.2 M (+3.24 %) |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | X | 0.68 | 238,850 | 161,224 | 6,533,135 | 6.3 M to 6.5 M (+3.79 %) |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 26,292,961 | 0 | 70,865,132 | 44.6 M to 70.9 M (+58.99 %) |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 1,912,167 | 0 | 6,294,285 | 4.4 M to 6.3 M (+43.64 %) |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 582,747 | 0 | 582,747 | 0 to 582.7 K |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 44,572,171 | 0 | 44,572,171 | 0 to 44.6 M |
| Feb 09 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 4,382,118 | 0 | 4,382,118 | 0 to 4.4 M |
| Feb 09 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.33 | 45,000 | 284,657 | 12,894,240 | 12.8 M to 12.9 M (+0.35 %) |
| Feb 04 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.65 | 24,800 | 164,915 | 12,849,240 | 12.8 M to 12.8 M (+0.19 %) |
| Feb 04 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.29 | 91,187 | 573,311 | 12,824,440 | 12.7 M to 12.8 M (+0.72 %) |
| Feb 04 2016 | BCRX | BIOCRYST PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 6.52 | 91,728 | 598,360 | 12,733,253 | 12.6 M to 12.7 M (+0.73 %) |